Page last updated: 2024-08-23

silybin and HIV

silybin has been researched along with HIV in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	3 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Agarwal, C; Agarwal, R; Caruso, T; De Tommaso, G; Di Fabio, G; Iuliano, M; Pannecouque, C; Romanucci, V; Zarrelli, A	1
Anagnostopoulos, A; Aouri, M; Böni, J; Braun, DL; Decosterd, L; Durisch, N; Eberhard, N; Fehr, J; Ledergerber, B; Metzner, KJ; Müllhaupt, B; Rauch, A; Weber, R	1
Beinhardt, S; Ferenci, P; Payer, BA; Peck-Radosavljevic, M; Reiberger, T; Rutter, K; Staettermayer, AF	1

Trials

1 trial(s) available for silybin and HIV

Article	Year
A Lead-In with Silibinin Prior to Triple-Therapy Translates into Favorable Treatment Outcomes in Difficult-To-Treat HIV/Hepatitis C Coinfected Patients. PloS one, 2015, Volume: 10, Issue:7 Topics: Adult; Antiretroviral Therapy, Highly Active; Antiviral Agents; Coinfection; Drug Administration Schedule; Female; Hepacivirus; Hepatitis C, Chronic; HIV; HIV Infections; Humans; Injections, Intravenous; Interferon-alpha; Liver Cirrhosis; Male; Middle Aged; Oligopeptides; Patient Safety; Polyethylene Glycols; Prospective Studies; Protease Inhibitors; Recombinant Proteins; Ribavirin; RNA, Viral; Silybin; Silymarin; Treatment Outcome; Viral Load	2015

Article

Year

A Lead-In with Silibinin Prior to Triple-Therapy Translates into Favorable Treatment Outcomes in Difficult-To-Treat HIV/Hepatitis C Coinfected Patients.

PloS one, 2015, Volume: 10, Issue:7

Topics: Adult; Antiretroviral Therapy, Highly Active; Antiviral Agents; Coinfection; Drug Administration Schedule; Female; Hepacivirus; Hepatitis C, Chronic; HIV; HIV Infections; Humans; Injections, Intravenous; Interferon-alpha; Liver Cirrhosis; Male; Middle Aged; Oligopeptides; Patient Safety; Polyethylene Glycols; Prospective Studies; Protease Inhibitors; Recombinant Proteins; Ribavirin; RNA, Viral; Silybin; Silymarin; Treatment Outcome; Viral Load

2015

Other Studies

2 other study(ies) available for silybin and HIV

Article	Year
Silibinin phosphodiester glyco-conjugates: Synthesis, redox behaviour and biological investigations. Bioorganic chemistry, 2018, Volume: 77 Topics: Antiviral Agents; Cell Death; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Glycoconjugates; HIV; Humans; Molecular Structure; Organophosphates; Oxidation-Reduction; PC-3 Cells; Silybin; Structure-Activity Relationship	2018
Successful HCV eradication and inhibition of HIV replication by intravenous silibinin in an HIV-HCV coinfected patient. Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 2010, Volume: 49, Issue:2 Topics: Adult; Antiviral Agents; CD4 Lymphocyte Count; Female; Hepacivirus; Hepatitis C, Chronic; HIV; HIV Infections; Humans; Interferon alpha-2; Interferon-alpha; Polyethylene Glycols; Recombinant Proteins; Ribavirin; RNA, Viral; Silybin; Silymarin; Treatment Outcome; Viral Load	2010

Article

Year

Silibinin phosphodiester glyco-conjugates: Synthesis, redox behaviour and biological investigations.

Bioorganic chemistry, 2018, Volume: 77

Topics: Antiviral Agents; Cell Death; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Glycoconjugates; HIV; Humans; Molecular Structure; Organophosphates; Oxidation-Reduction; PC-3 Cells; Silybin; Structure-Activity Relationship

2018

Successful HCV eradication and inhibition of HIV replication by intravenous silibinin in an HIV-HCV coinfected patient.

Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 2010, Volume: 49, Issue:2

Topics: Adult; Antiviral Agents; CD4 Lymphocyte Count; Female; Hepacivirus; Hepatitis C, Chronic; HIV; HIV Infections; Humans; Interferon alpha-2; Interferon-alpha; Polyethylene Glycols; Recombinant Proteins; Ribavirin; RNA, Viral; Silybin; Silymarin; Treatment Outcome; Viral Load

2010